Effectiveness of Glycyrrhizin as Intracanal Medication in Root Canal Disinfection and Inflammatory Cytokines

Trial statusRecruiting
Trial phasePhase 2, Phase 3
Trial typeInterventional
Biological sexAll
Age20-60
SponsorMansoura University

About this trial

The objective of this study is to investigate "clinically" the effectiveness of Glycyrrhizin based intracanal medication compared to the commonly used intracanal medicaments (calcium hydroxide Ca(OH)2 and Ledermix) on the levels of bacteria and inflammatory cytokines in root canals and periradicular tissues of teeth with apical periodontitis.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

Single-rooted with pulp necrosis and apical periodontitis.

Disqualifiers

Receiving antibiotic treatment within the preceding 3 months.

Reporting systemic disease.

Teeth that could not be isolated with rubber dam.

Teeth with periodontal pockets deeper than 3 mm.

Trial design

Design model

Crossover

Treatments tested in this trial

  • Calcium Hydroxide

    Drug

    Intracanal medication

  • Leddermix

    Drug

    Intracanal medication

  • Glycirrhizin

    Drug

    Intracanal medication

Treatment groups

36 Participants
are divided into 3 treatment groups
Group A: Calcium HydroxideActive comparator 1 intervention
Group B: LeddermixActive comparator 1 intervention
Group C: GlycirrhizinActive comparator 1 intervention

Trial outcomes

Primary outcomes

1

counting the number of colonies forming units of bacterial cells

Microbiology cell culturing (manual counting technique to the bacterial cells)

Time frame
up to 7 months

Secondary outcomes

Other outcomes

1

using enzyme-linked immunosorbent assay (ELISA test) to measure the amount of Inflammatory Cytokines (TNF-α), (IL-1β) and (PG2)

ELISA test to measure the amount of tumor necrotizing factor (TNF-α), interleukin 1β(IL-1β) and prostaglandin E2 (PG2)

Time frame
25 weeks

Sponsors and contacts

Click on the lead sponsor to view all of their trials.